NCT03056456 - A Study of LY900014 Administered in Participants With Type 1 Diabetes Using an Insulin Pump | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 23, 2017

Primary Completion Date

June 19, 2017

Study Completion Date

June 19, 2017

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG

LY900014

Administered subcutaneously (SC)

DRUG

Insulin Lispro (Humalog)

Administered SC

Trial Locations (2)

41460

For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician., Neuss

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician., Neuss

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY